Smith, Moore & Co’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369K | Hold |
300,000
| – | – | 0.03% | 351 |
|
|
2025
Q1 | $330K | Hold |
300,000
| – | – | 0.03% | 358 |
|
|
2024
Q4 | $271K | Buy |
300,000
+74,000
| +33% | +$66.9K | 0.02% | 391 |
|
|
2024
Q3 | $223K | Hold |
226,000
| – | – | 0.02% | 420 |
|
|
2024
Q2 | $204K | Buy |
226,000
+100,000
| +79% | +$90.1K | 0.02% | 426 |
|
|
2024
Q1 | $149K | Hold |
126,000
| – | – | 0.02% | 417 |
|
|
2023
Q4 | $115K | Buy |
126,000
+60,000
| +91% | +$54.8K | 0.01% | 402 |
|
|
2023
Q3 | $55K | Hold |
66,000
| – | – | 0.01% | 378 |
|
|
2023
Q2 | $79.2K | Hold |
66,000
| – | – | 0.01% | 389 |
|
|
2023
Q1 | $83.2K | Buy |
66,000
+41,000
| +164% | +$51.7K | 0.01% | 378 |
|
|
2022
Q4 | $54.3K | Buy |
25,000
+10,000
| +67% | +$21.7K | 0.01% | 371 |
|
|
2022
Q3 | $180K | Buy |
+15,000
| New | +$180K | 0.03% | 352 |
|
|
2022
Q2 | – | Sell |
-19,500
| Closed | -$169K | – | 405 |
|
|
2022
Q1 | $169K | Hold |
19,500
| – | – | 0.02% | 397 |
|
|
2021
Q4 | $221K | Buy |
19,500
+9,500
| +95% | +$108K | 0.03% | 375 |
|
|
2021
Q3 | $126K | Buy |
+10,000
| New | +$126K | 0.02% | 406 |
|